• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型三联修饰秋水仙碱衍生物作为有效的微管蛋白靶向抗癌剂的合成与生物学评价

Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents.

作者信息

Majcher Urszula, Klejborowska Greta, Kaik Magdalena, Maj Ewa, Wietrzyk Joanna, Moshari Mahshad, Preto Jordane, Tuszynski Jack A, Huczyński Adam

机构信息

Department of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznan, Poland.

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, Poland.

出版信息

Cells. 2018 Nov 19;7(11):216. doi: 10.3390/cells7110216.

DOI:10.3390/cells7110216
PMID:30463236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6262455/
Abstract

Specific modifications of colchicine followed by synthesis of its analogues have been tested in vitro with the objective of lowering colchicine toxicity. Our previous studies have clearly shown the anticancer potential of double-modified colchicine derivatives in C-7 and C-10 positions. Here, a series of novel triple-modified colchicine derivatives is reported. They have been obtained following a four-step strategy. In vitro cytotoxicity of these compounds has been evaluated against four human tumor cell lines (A549, MCF-7, LoVo, and LoVo/DX). Additionally, the mode of binding of the synthesized compounds was evaluated in silico using molecular docking to a 3D structure of β-tubulin based on crystallographic data from the Protein Data Bank and homology methodology. Binding free energy estimates, binding poses, and MlogP values of the compounds were obtained. All triple-modified colchicine derivatives were shown to be active at nanomolar concentrations against three of the investigated cancer cell lines (A549, MCF-7, LoVo). Four of them also showed higher potency against tumor cells over normal cells as confirmed by their high selectivity index values. A vast majority of the synthesized derivatives exhibited several times higher cytotoxicity than colchicine, doxorubicin, and cisplatin.

摘要

为降低秋水仙碱的毒性,人们对秋水仙碱进行了特定修饰并合成了其类似物,且已在体外进行了测试。我们之前的研究清楚地表明了在C-7和C-10位双修饰秋水仙碱衍生物的抗癌潜力。在此,报道了一系列新型三修饰秋水仙碱衍生物。它们是通过四步策略获得的。已针对四种人类肿瘤细胞系(A549、MCF-7、LoVo和LoVo/DX)评估了这些化合物的体外细胞毒性。此外,基于蛋白质数据库的晶体学数据和同源方法,使用分子对接至β-微管蛋白的3D结构,在计算机上评估了合成化合物的结合模式。获得了化合物的结合自由能估计值、结合姿势和MlogP值。所有三修饰秋水仙碱衍生物在纳摩尔浓度下对三种被研究的癌细胞系(A549、MCF-7、LoVo)均表现出活性。其中四种还因其高选择性指数值而显示出对肿瘤细胞的效力高于正常细胞。绝大多数合成衍生物表现出比秋水仙碱、阿霉素和顺铂高几倍的细胞毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/6262455/86372b86a84c/cells-07-00216-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/6262455/80a15149d7eb/cells-07-00216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/6262455/86372b86a84c/cells-07-00216-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/6262455/80a15149d7eb/cells-07-00216-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/752b/6262455/86372b86a84c/cells-07-00216-g004.jpg

相似文献

1
Synthesis and Biological Evaluation of Novel Triple-Modified Colchicine Derivatives as Potent Tubulin-Targeting Anticancer Agents.新型三联修饰秋水仙碱衍生物作为有效的微管蛋白靶向抗癌剂的合成与生物学评价
Cells. 2018 Nov 19;7(11):216. doi: 10.3390/cells7110216.
2
Antiproliferative Activity and Molecular Docking of Novel Double-Modified Colchicine Derivatives.新型双修饰秋水仙碱衍生物的抗增殖活性及分子对接
Cells. 2018 Nov 1;7(11):192. doi: 10.3390/cells7110192.
3
Synthesis, antiproliferative activity, and molecular docking studies of 4-chlorothiocolchicine analogues.合成、抗增殖活性及 4-氯硫代秋水仙碱类似物的分子对接研究。
Chem Biol Drug Des. 2020 Jan;95(1):182-191. doi: 10.1111/cbdd.13618. Epub 2019 Sep 20.
4
Synthesis, anticancer activity and molecular docking studies of N-deacetylthiocolchicine and 4-iodo-N-deacetylthiocolchicine derivatives.N-去乙酰硫代秋水仙碱和 4-碘-N-去乙酰硫代秋水仙碱衍生物的合成、抗癌活性及分子对接研究。
Bioorg Med Chem. 2021 Feb 15;32:116014. doi: 10.1016/j.bmc.2021.116014. Epub 2021 Jan 11.
5
Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.硫代秋水仙碱尿烷的合成、抗增殖活性及分子对接。
Bioorg Chem. 2018 Dec;81:553-566. doi: 10.1016/j.bioorg.2018.09.004. Epub 2018 Sep 12.
6
New Series of Double-Modified Colchicine Derivatives: Synthesis, Cytotoxic Effect and Molecular Docking.新型双修饰秋水仙碱衍生物系列:合成、细胞毒性作用及分子对接。
Molecules. 2020 Aug 2;25(15):3540. doi: 10.3390/molecules25153540.
7
Synthesis, biological evaluation and molecular docking studies of new amides of 4-bromothiocolchicine as anticancer agents.新型 4-溴硫代秋水仙酰胺类化合物的合成、生物评价及分子对接研究。
Bioorg Med Chem. 2019 Dec 1;27(23):115144. doi: 10.1016/j.bmc.2019.115144. Epub 2019 Oct 8.
8
Synthesis, Antiproliferative Activity and Molecular Docking Studies of Novel Doubly Modified Colchicine Amides and Sulfonamides as Anticancer Agents.新型双修饰秋水仙酰胺和磺酰胺类化合物的合成、抗增殖活性及分子对接研究及其作为抗癌药物。
Molecules. 2020 Apr 14;25(8):1789. doi: 10.3390/molecules25081789.
9
Synthesis, antiproliferative activity and molecular docking of Colchicine derivatives.秋水仙碱衍生物的合成、抗增殖活性及分子对接。
Bioorg Chem. 2016 Feb;64:103-12. doi: 10.1016/j.bioorg.2016.01.002. Epub 2016 Jan 12.
10
Synthesis, biological evaluation and molecular docking studies of new amides of 4-chlorothiocolchicine as anticancer agents.新型 4-氯硫代秋水仙酰胺类化合物的合成、生物评价及分子对接研究。
Bioorg Chem. 2020 Apr;97:103664. doi: 10.1016/j.bioorg.2020.103664. Epub 2020 Feb 13.

引用本文的文献

1
Design, synthesis and antiproliferative activity of novel colchicine derivatives: selective inhibition of melanoma cell proliferation.新型秋水仙碱衍生物的设计、合成及抗增殖活性:对黑色素瘤细胞增殖的选择性抑制
Front Pharmacol. 2025 Jun 27;16:1528235. doi: 10.3389/fphar.2025.1528235. eCollection 2025.
2
Changes in Key Aroma Compounds and Esterase Activity of -Fermented Cheese across a 30-Day Ripening Period.在30天成熟期间,γ-发酵奶酪关键香气化合物和酯酶活性的变化。
Foods. 2022 Dec 13;11(24):4026. doi: 10.3390/foods11244026.
3
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity.

本文引用的文献

1
Synthesis, antiproliferative activity and molecular docking of thiocolchicine urethanes.硫代秋水仙碱尿烷的合成、抗增殖活性及分子对接。
Bioorg Chem. 2018 Dec;81:553-566. doi: 10.1016/j.bioorg.2018.09.004. Epub 2018 Sep 12.
2
Modeling the Colchicum autumnale Tubulin and a Comparison of Its Interaction with Colchicine to Human Tubulin.秋水仙碱微管蛋白建模及其与秋水仙素相互作用与人类微管蛋白的比较。
Int J Mol Sci. 2017 Aug 2;18(8):1676. doi: 10.3390/ijms18081676.
3
Tools for the rational design of bivalent microtubule-targeting drugs.
苯并三唑取代的 2-苯基喹唑啉类化合物作为抗癌剂:合成、筛选、抗增殖和微管蛋白聚合抑制活性。
Curr Cancer Drug Targets. 2023;23(4):278-292. doi: 10.2174/1568009623666221028121906.
4
Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.天然和合成查尔酮的两种重要抗癌机制。
Int J Mol Sci. 2022 Sep 30;23(19):11595. doi: 10.3390/ijms231911595.
5
Antiproliferative Potential of Gloriosine: A Lead for Anticancer Drug Development.光辉菌素的抗增殖潜力:抗癌药物开发的先导物
ACS Omega. 2022 Aug 12;7(33):28994-29001. doi: 10.1021/acsomega.2c02688. eCollection 2022 Aug 23.
6
Synthesis and Antiproliferative Evaluation of 3-Chloroazetidin-2-ones with Antimitotic Activity: Heterocyclic Bridged Analogues of Combretastatin A-4.具有抗有丝分裂活性的3-氯氮杂环丁烷-2-酮的合成与抗增殖评价:康普瑞他汀A-4的杂环桥连类似物
Pharmaceuticals (Basel). 2021 Oct 31;14(11):1119. doi: 10.3390/ph14111119.
7
Antiviral, Cytotoxic, and Antioxidant Activities of Three Edible Agaricomycetes Mushrooms: , , and .三种可食用伞菌蘑菇的抗病毒、细胞毒性和抗氧化活性:[具体蘑菇名称1]、[具体蘑菇名称2]和[具体蘑菇名称3] 。 (你提供的原文中蘑菇名称部分缺失,这里补充了注释说明)
J Fungi (Basel). 2021 Aug 8;7(8):645. doi: 10.3390/jof7080645.
8
Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment.植物抗癌化合物在癌症治疗中的现状与挑战
Pharmaceuticals (Basel). 2021 Feb 14;14(2):157. doi: 10.3390/ph14020157.
9
Mitotic Poisons in Research and Medicine.有丝分裂毒物在研究和医学中的应用。
Molecules. 2020 Oct 12;25(20):4632. doi: 10.3390/molecules25204632.
10
Synthesis and Antiproliferative Screening Of Novel Analogs of Regioselectively Demethylated Colchicine and Thiocolchicine.新型区域选择性去甲基秋水仙碱和硫代秋水仙碱类似物的合成及抗增殖筛选。
Molecules. 2020 Mar 5;25(5):1180. doi: 10.3390/molecules25051180.
用于二价微管靶向药物合理设计的工具。
Biochem Biophys Res Commun. 2016 Oct 7;479(1):48-53. doi: 10.1016/j.bbrc.2016.09.022. Epub 2016 Sep 7.
4
Colchicine for cardiovascular medicine.用于心血管医学的秋水仙碱。
Future Cardiol. 2016 Jan;12(1):9-16. doi: 10.2217/fca.15.59. Epub 2015 Dec 3.
5
PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data.PTRAJ和CPPTRAJ:用于处理和分析分子动力学轨迹数据的软件。
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95. doi: 10.1021/ct400341p. Epub 2013 Jun 25.
6
Colchicine: old and new.秋水仙碱:新旧情况
Am J Med. 2015 May;128(5):461-70. doi: 10.1016/j.amjmed.2014.12.010. Epub 2014 Dec 30.
7
Cheburator software for automatically calculating drug inhibitory concentrations from in vitro screening assays.用于从体外筛选试验自动计算药物抑制浓度的Cheburator软件。
PLoS One. 2014 Sep 3;9(9):e106186. doi: 10.1371/journal.pone.0106186. eCollection 2014.
8
Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.微管蛋白抑制剂:药效团建模、虚拟筛选与分子对接
Acta Pharmacol Sin. 2014 Jul;35(7):967-79. doi: 10.1038/aps.2014.34. Epub 2014 Jun 9.
9
Design, Synthesis, and Antitumor Activity of 4-Halocolchicines and Their Pro-drugs Activated by Cathepsin B.组织蛋白酶B激活的4-卤代秋水仙碱及其前药的设计、合成与抗肿瘤活性
ACS Med Chem Lett. 2011 Mar 4;2(5):348-52. doi: 10.1021/ml100287y. eCollection 2011 May 12.
10
Tubulin: an example of targeted chemotherapy.微管蛋白:靶向化疗的一个例子。
Future Med Chem. 2013 Mar;5(3):339-52. doi: 10.4155/fmc.12.217.